SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The "crow with knife" meme coin, $CAW, is trending with community members frequently repeating the phrase "crow with knife is the only option". The coin is described as multichain, deflationary, and community-driven, with supporters emphasizing its organic nature and active community.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending as community members rally around the project's real-world applications and brand initiatives, including skateboards, energy drinks and more, with new products and partnerships being actively discussed. The community emphasizes its strong, active, and supportive nature, highlighting the various ways they are building the KENDU brand in real life. Bullish community members are focused on growing the brand and reaching new milestones.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

The crypto, $SLAP, is trending as the community rallies around it, using the term 'slap' to express enthusiasm and action against market downturns. Community members highlight the project's consistency, daily grind, and support from figures like MMA fighter Karolina Arm. Many express bullish sentiment and encourage others to 'slap' the competition and the bears.

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium (CCD) is trending due to its recent partnership with bitcoin.com for age-verified stablecoin payments, sparking community excitement and discussions around its potential. Some view CCD as an undervalued privacy and identity-focused project with strong long-term potential, drawing comparisons to ZEC. The project's focus on compliant, enterprise-ready blockchain solutions and growing institutional interest are also key talking points.

Monero

Monero is trending as the community emphasizes its role as a leading privacy coin, with some anticipating a significant breakout despite past delistings from major exchanges. Discussions highlight Monero's potential use cases amidst growing concerns over financial surveillance and the rise of CBDCs. Community members are also actively discussing mining Monero, viewing it as a means to secure the network and accumulate value.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as community members rally behind its grassroots foundation and fair distribution, highlighting its potential as a leading meme coin on the Bitcoin network. Discussion focuses on the growing $DOG treasury and the increasing recognition from major players in the crypto space. Some community members also express excitement about potential exchange listings and increased exposure to retail investors.

Peanut the Squirrel Markets

$PNUT is trending amid community excitement and volatility, with traders actively discussing potential price movements and quick gains. Some users are comparing it to other meme coins like $DOGE and $SHIB, while others are focused on technical analysis and trading strategies to capitalize on short-term pumps. The coin seems to be benefiting from a broader meme coin rally, with community members expressing bullish sentiment and speculating on future price targets.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. is trending amid community discussion around potential new contracts, particularly with TikTok, which could significantly boost revenue. The community is also focused on the company's growing presence in the AI data sector and potential government contracts, fueled by recent executive hires. Some investors believe upcoming earnings will be a catalyst to the stock price rallying significantly.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending due to positive Phase 1 data for its CTX310 therapy, showing significant cholesterol reduction with a promising safety profile, sparking excitement about its potential. The community is discussing the implications of these results, especially the potential for a blockbuster drug and the validation of CRISPR's in vivo LNP delivery platform. Despite a recent price target reduction from Wedbush, the positive data and insider buying activity fuel optimism about the stock's future.

Veritone, Inc. engages in the provision of artificial intelligence (AI) computing solutions to media and entertainment, government, and legal and compliance industries. It operates through the following segments: Advertising, aiWARE SaaS Solutions, and aiWARE Content Licensing and Media Services. The Advertising segment places advertisements for clients, primarily with radio broadcasters, podcasters and digital media producers. The aiWARE SaaS Solutions segment offers solutions through a combination of its direct sales force and indirect channel partners, such as value-added resellers (VARs), distributors, system integrators, managed services providers, and referral partners. The aiWARE Content Licensing and Media Services segment sells and markets activities relating to its digital content licensing services business through its direct sales force. The company was founded by Chad Edward Steelberg and Ryan S. Steelberg on June 13, 2014 and is headquartered in Irvine, CA.

Veritone Inc

VERI is trending due to positive analyst coverage and discussions around its growth potential in the AI data refinement sector, particularly with its VDR product. Community members are actively discussing new partnerships with hyperscalers, revenue projections, and the company's strengthened balance sheet following debt reduction. Some are frustrated by recent price action, attributing it to market manipulation and dilution, while others remain bullish, anticipating significant upside and a potential buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: LENZ Therapeutics (NASDAQ:LENZ) CFO Acquires 2,198 Shares of Stock

LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) CFO Daniel Chevallard acquired 2,198 shares of LENZ Therapeutics stock in a transaction that occurred on Friday, November 7th. The stock was...

Brokers Set Expectations for LENZ Q3 Earnings

LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Equities research analysts at HC Wainwright issued their Q3 2026 earnings per share estimates for shares of LENZ Therapeutics in a note issued to...

William Blair Predicts Weaker Earnings for LENZ Therapeutics

LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Equities researchers at William Blair decreased their FY2025 earnings per share estimates for LENZ Therapeutics in a report released on...

LENZ Therapeutics (NASDAQ:LENZ) Announces Earnings Results

LENZ Therapeutics (NASDAQ:LENZ - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.59) earnings per share (EPS) for the quarter, topping the consensus...

LENZ Therapeutics (NASDAQ:LENZ) Shares Gap Down - Time to Sell?

LENZ Therapeutics (NASDAQ:LENZ) Shares Gap Down - Here's Why...

LENZ Therapeutics, Inc. (LENZ) Reports Q3 Loss, Beats Revenue Estimates

LENZ Therapeutics, Inc. (LENZ) delivered earnings and revenue surprises of +11.94% and +92.31%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

LENZ Therapeutics, Inc. (LENZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

After losing some value lately, a hammer chart pattern has been formed for LENZ Therapeutics, Inc. (LENZ), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

LENZ Therapeutics, Inc. (LENZ) Upgraded to Buy: What Does It Mean for the Stock?

LENZ Therapeutics, Inc. (LENZ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LENZ Therapeutics, Inc. (LENZ) is a Great Momentum Stock: Should You Buy?

Does LENZ Therapeutics, Inc. (LENZ) have what it takes to be a top stock pick for momentum investors? Let's find out.

Does LENZ Therapeutics, Inc. (LENZ) Have the Potential to Rally 30.86% as Wall Street Analysts Expect?

The consensus price target hints at a 30.9% upside potential for LENZ Therapeutics, Inc. (LENZ). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.

LENZ Therapeutics Inc.

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.95	--	--	N/A
Q3 '25	-$0.69	-$0.59	14.78%	BEAT
Q2 '25	-$0.61	-$0.53	13.15%	BEAT
Q1 '25	-$0.52	-$0.53	-2.25%	MISSED
Q4 '24	-$0.41	-$0.46	-12.20%	MISSED

LENZ
LENZ Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest LENZ News

LENZLENZ Therapeutics Inc.